Literature DB >> 9689132

Absence of neurofilaments reduces the selective vulnerability of motor neurons and slows disease caused by a familial amyotrophic lateral sclerosis-linked superoxide dismutase 1 mutant.

T L Williamson1, L I Bruijn, Q Zhu, K L Anderson, S D Anderson, J P Julien, D W Cleveland.   

Abstract

Mutations in superoxide dismutase 1 (SOD1), the only proven cause of amyotrophic lateral sclerosis (ALS), provoke disease through an unidentified toxic property. Neurofilament aggregates are pathologic hallmarks of both sporadic and SOD1-mediated familial ALS. By deleting NF-L, the major neurofilament subunit required for filament assembly, onset and progression of disease caused by familial ALS-linked SOD1 mutant G85R are significantly slowed, while selectivity of mutant-mediated toxicity for motor neurons is reduced. In NF-L-deleted animals, levels of the two remaining neurofilament subunits, NF-M and NF-H, are markedly reduced in axons but are elevated in motor neuron cell bodies. Thus, while neither perikaryal nor axonal neurofilaments are essential for SOD1-mediated disease, the absence of assembled neurofilaments both diminishes selective vulnerability and slows SOD1(G85R) mutant-mediated toxicity to motor neurons.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9689132      PMCID: PMC21390          DOI: 10.1073/pnas.95.16.9631

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  60 in total

1.  Proximal axonal enlargement in motor neuron disease.

Authors:  S Carpenter
Journal:  Neurology       Date:  1968-09       Impact factor: 9.910

2.  Quantitative immunocytochemical analysis of the spinal cord in G86R superoxide dismutase transgenic mice: neurochemical correlates of selective vulnerability.

Authors:  B M Morrison; J W Gordon; M E Ripps; J H Morrison
Journal:  J Comp Neurol       Date:  1996-09-30       Impact factor: 3.215

3.  Slowing of the axonal transport of neurofilament proteins during development.

Authors:  P N Hoffman; R J Lasek; J W Griffin; D L Price
Journal:  J Neurosci       Date:  1983-08       Impact factor: 6.167

4.  Fine structural study of neurofibrillary changes in a family with amyotrophic lateral sclerosis.

Authors:  A Hirano; I Nakano; L T Kurland; D W Mulder; P W Holley; G Saccomanno
Journal:  J Neuropathol Exp Neurol       Date:  1984-09       Impact factor: 3.685

5.  Distribution of a novel 57 kDa intermediate filament (IF) protein in the nervous system.

Authors:  L M Parysek; R D Goldman
Journal:  J Neurosci       Date:  1988-02       Impact factor: 6.167

6.  Fine structural observations of neurofilamentous changes in amyotrophic lateral sclerosis.

Authors:  A Hirano; H Donnenfeld; S Sasaki; I Nakano
Journal:  J Neuropathol Exp Neurol       Date:  1984-09       Impact factor: 3.685

7.  Modulations of neurofilament axonal transport during the development of rabbit retinal ganglion cells.

Authors:  M Willard; C Simon
Journal:  Cell       Date:  1983-12       Impact factor: 41.582

8.  Morphometric comparison of the vulnerability of peripheral motor and sensory neurons in amyotrophic lateral sclerosis.

Authors:  Y Kawamura; P J Dyck; M Shimono; H Okazaki; J Tateishi; H Doi
Journal:  J Neuropathol Exp Neurol       Date:  1981-11       Impact factor: 3.685

9.  Calcium binding to untreated and dephosphorylated porcine neurofilaments.

Authors:  S Lefebvre; W E Mushynski
Journal:  Biochem Biophys Res Commun       Date:  1987-06-30       Impact factor: 3.575

10.  A nerve growth factor-regulated messenger RNA encodes a new intermediate filament protein.

Authors:  D G Leonard; J D Gorham; P Cole; L A Greene; E B Ziff
Journal:  J Cell Biol       Date:  1988-01       Impact factor: 10.539

View more
  47 in total

1.  Reduction of axonal caliber does not alleviate motor neuron disease caused by mutant superoxide dismutase 1.

Authors:  M D Nguyen; R C Larivière; J P Julien
Journal:  Proc Natl Acad Sci U S A       Date:  2000-10-24       Impact factor: 11.205

Review 2.  Progress in the pathogenesis of amyotrophic lateral sclerosis.

Authors:  C E Shaw; A al-Chalabi; N Leigh
Journal:  Curr Neurol Neurosci Rep       Date:  2001-01       Impact factor: 5.081

3.  Calcium dynamics and buffering in oculomotor neurones from mouse that are particularly resistant during amyotrophic lateral sclerosis (ALS)-related motoneurone disease.

Authors:  B K Vanselow; B U Keller
Journal:  J Physiol       Date:  2000-06-01       Impact factor: 5.182

Review 4.  Complex genetics of amyotrophic lateral sclerosis.

Authors:  Catherine B Kunst
Journal:  Am J Hum Genet       Date:  2004-10-11       Impact factor: 11.025

5.  Peripherin is a subunit of peripheral nerve neurofilaments: implications for differential vulnerability of CNS and peripheral nervous system axons.

Authors:  Aidong Yuan; Takahiro Sasaki; Asok Kumar; Corrinne M Peterhoff; Mala V Rao; Ronald K Liem; Jean-Pierre Julien; Ralph A Nixon
Journal:  J Neurosci       Date:  2012-06-20       Impact factor: 6.167

6.  Calpastatin inhibits motor neuron death and increases survival of hSOD1(G93A) mice.

Authors:  Mala V Rao; Jabbar Campbell; Arti Palaniappan; Asok Kumar; Ralph A Nixon
Journal:  J Neurochem       Date:  2016-03-23       Impact factor: 5.372

Review 7.  Catalytic antioxidants to treat amyotropic lateral sclerosis.

Authors:  John P Crow
Journal:  Expert Opin Investig Drugs       Date:  2006-11       Impact factor: 6.206

Review 8.  Review of the multiple aspects of neurofilament functions, and their possible contribution to neurodegeneration.

Authors:  Rodolphe Perrot; Raphael Berges; Arnaud Bocquet; Joel Eyer
Journal:  Mol Neurobiol       Date:  2008-07-23       Impact factor: 5.590

Review 9.  The wobbler mouse: a neurodegeneration jigsaw puzzle.

Authors:  Séverine Boillée; Marc Peschanski; Marie-Pierre Junier
Journal:  Mol Neurobiol       Date:  2003-08       Impact factor: 5.590

10.  Chemical induction of misfolded prion protein conformers in cell culture.

Authors:  Sina Ghaemmaghami; Julie Ullman; Misol Ahn; Susan St Martin; Stanley B Prusiner
Journal:  J Biol Chem       Date:  2009-12-02       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.